ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00010	Glycolysis / Gluconeogenesis	9/78	74/7206	7.98310042207e-08
ko01200	Carbon metabolism	11/78	128/7206	1.02263263726e-07
ko05410	Hypertrophic cardiomyopathy (HCM)	8/78	100/7206	1.09248257716e-05
ko04921	Oxytocin signaling pathway	11/78	209/7206	1.32812237206e-05
ko00680	Methane metabolism	5/78	34/7206	2.84192815539e-05
ko01230	Biosynthesis of amino acids	7/78	85/7206	3.32480016934e-05
ko05012	Parkinson's disease	9/78	155/7206	4.01202094614e-05
ko04152	AMPK signaling pathway	9/78	161/7206	5.40803754447e-05
ko00190	Oxidative phosphorylation	8/78	127/7206	6.22381738669e-05
ko04932	Non-alcoholic fatty liver disease (NAFLD)	9/78	182/7206	0.000139469935639
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	6/78	79/7206	0.000196560031637
ko05010	Alzheimer's disease	9/78	202/7206	0.000305613841444
ko04922	Glucagon signaling pathway	7/78	128/7206	0.000439105842785
ko05016	Huntington's disease	9/78	215/7206	0.000483759101161
ko04260	Cardiac muscle contraction	6/78	98/7206	0.000632681844457
ko05414	Dilated cardiomyopathy	6/78	112/7206	0.00127589766796
ko00620	Pyruvate metabolism	4/78	46/7206	0.00146864305144
ko00710	Carbon fixation in photosynthetic organisms	3/78	27/7206	0.0029600957494
ko00030	Pentose phosphate pathway	3/78	32/7206	0.00482867519532
ko00640	Propanoate metabolism	3/78	34/7206	0.00573607930424
ko00051	Fructose and mannose metabolism	3/78	42/7206	0.0103451371539
ko04723	Retrograde endocannabinoid signaling	6/78	175/7206	0.0114172878831
ko03018	RNA degradation	4/78	84/7206	0.0127519139626
ko00230	Purine metabolism	6/78	194/7206	0.0181994982572
ko01210	2-Oxocarboxylic acid metabolism	2/78	20/7206	0.0193735114222
ko04261	Adrenergic signaling in cardiomyocytes	6/78	205/7206	0.0231890411566
ko04270	Vascular smooth muscle contraction	5/78	154/7206	0.0252942682679
ko00220	Arginine biosynthesis	2/78	24/7206	0.0273712137636